Daniel J. Brennan Boston Scientific Corp (BSX) insider trading activity

Daniel J. Brennan is EVP and CFO of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 223,921 shares of BSX, which is worth approximately $20.4 Million. The most recent transaction as insider was on Feb 17, 2023, when has been sold 4,583 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 224K

0% 3M change

0.9% 12M change

Total Value Held $20.4 Million

Daniel J. Brennan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2023	BUY Exercise of conversion of derivative security	-	4,583 Added 1.59%	283,892 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$58,099 $46.48 p/Share	1,250 Reduced 0.45%	279,309 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	4,243 Added 1.49%	280,559 Common Stock
Feb 15 2023	SELL Open market or private sale	$356,944 $47.14 p/Share	7,572 Reduced 2.67%	276,316 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$57,646 $47.29 p/Share	1,219 Reduced 0.43%	283,888 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	$43,382 $3.7 p/Share	11,725 Added 3.95%	285,107 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$187,023 $46.27 p/Share	4,042 Reduced 1.46%	273,382 Common Stock
Jan 01 2023	BUY Exercise of conversion of derivative security	-	13,134 Added 4.52%	277,424 Common Stock
Mar 02 2022	SELL Open market or private sale	$485,607 $44.03 p/Share	11,029 Reduced 4.01%	264,290 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$87,810 $44.17 p/Share	1,988 Reduced 0.72%	275,319 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	4,481 Added 1.59%	277,307 Common Stock
Feb 22 2022	SELL Open market or private sale	$2,273,530 $42.75 p/Share	53,182 Reduced 16.31%	272,826 Common Stock
Feb 22 2022	BUY Exercise of conversion of derivative security	$718,489 $13.51 p/Share	53,182 Added 14.03%	326,008 Common Stock
Feb 21 2022	SELL Payment of exercise price or tax liability	$69,101 $42.55 p/Share	1,624 Reduced 0.59%	272,826 Common Stock
Feb 21 2022	BUY Exercise of conversion of derivative security	-	3,661 Added 1.32%	274,450 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$69,952 $42.55 p/Share	1,644 Reduced 0.6%	270,789 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	3,706 Added 1.34%	272,433 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$87,073 $42.83 p/Share	2,033 Reduced 0.75%	268,727 Common Stock
Feb 17 2022	BUY Exercise of conversion of derivative security	-	4,583 Added 1.66%	270,760 Common Stock
Feb 16 2022	SELL Open market or private sale	$532,572 $43.7 p/Share	12,187 Reduced 4.38%	266,177 Common Stock
Feb 16 2022	BUY Exercise of conversion of derivative security	$76,534 $6.28 p/Share	12,187 Added 4.19%	278,364 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$53,648 $44.01 p/Share	1,219 Reduced 0.44%	275,313 Common Stock
Feb 15 2022	SELL Open market or private sale	$397,142 $43.47 p/Share	9,136 Reduced 3.32%	266,177 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	4,153 Added 1.48%	276,532 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$172,341 $42.48 p/Share	4,057 Reduced 1.47%	272,379 Common Stock

Also insider at

NUAN

Nuance Communications, Inc. Technology

Director

WAT

WATERS CORP Healthcare

Director

DJB

Daniel J. Brennan

EVP and CFO

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account